The Latest in Non-Hodgkin Lymphoma

Hematology Times

Drug shows promise for treating resistant AML, MCL

February 17, 2016

Hematology Times

Combo can produce durable remissions in PTCL

February 12, 2016

Hematology Times

Chemo regimen can be ‘highly effective’ against ENKTL

February 10, 2016

Hematology Times

Dual inhibitor could treat ATLL

February 9, 2016

Hematology Times

Immunotherapy proves active against MF, SS

February 5, 2016

Hematology Times

Mutations may impact response to HDACis in PTCL-NOS

February 4, 2016

Hematology Times

Lenalidomide shows promise for treating ATLL

February 3, 2016

Hematology Times

Study suggests chidamide could treat rel/ref CTCL too

February 2, 2016

Hematology Times

NICE issues draft guideline for NHL

February 1, 2016

Hematology Times

New insight into CLL development

January 25, 2016

Hematology Times

Drug granted another breakthrough designation for CLL

January 21, 2016

Hematology Times

FDA approves maintenance therapy for CLL

January 20, 2016

Hematology Times

Drug gets priority review as CLL treatment

January 13, 2016

Hematology Times

Increasing eligibility for engineered T-cell therapy

January 8, 2016

Hematology Times

How microbes drive progression of CTCL

January 7, 2016